Kazia Therapeutics (KZIA) Inventory Average (2009 - 2010)
Kazia Therapeutics (KZIA) posted Inventory Average of $1.2 million for Q4 2010, up 14.22% on a QoQ basis from $1.1 million in Q2 2010, and up 38.01% year-over-year from $882069.4 in Q4 2009.
Kazia Therapeutics (KZIA) has 2 years of Inventory Average data on file, last reported at $1.2 million in Q4 2010.
- In Q4 2010, Inventory Average rose 38.01% year-over-year to $1.2 million; the TTM figure through Dec 2010 stood at $1.2 million (up 38.01% YoY), while the FY2010 annual figure was $1.2 million, up 13.8% from the prior year.
- Inventory Average rose to $1.2 million in Q4 2010, from $1.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $1.2 million in Q4 2010 and bottomed at $882069.4 in Q4 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 1.22 Mn |
| Jun 30, 2010 | 1.07 Mn |
| Dec 31, 2009 | 882,069.44 |
| Jun 30, 2009 | 898,156.42 |